Press Releases FDA was Right to Decline Approval of MDMA-Assisted Therapy for PTSD and Encourage Further Research August 9, 2024
Letters, Testimony & Filings Outrage of the Month: Private Equity Firms: Stripping Hospital Assets and Threatening Patient Safety August 1, 2024
Letters, Testimony & Filings Comment to CMS Requesting a MEDCAC meeting for the EVOQUE Tricuspid Valve Replacement System July 18, 2024
Letters, Testimony & Filings Outrage of the Month: Tobacco Industry Sponsorship of Continuing Medical Education July 1, 2024
Letters, Testimony & Filings Comments on New Jersey’s Proposed Rule on Sexual Misconduct Education and Prevention June 14, 2024
Letters, Testimony & Filings Comments at the FDA’s Public Meeting: Optimizing FDA’s Use of and Processes for Advisory Committees June 13, 2024